| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Feb―23 |
Computational Evaluation of Withania somnifera Phytocompounds Targeting SARS-CoV-2 ORF9b Protein: Insights from Molecular Docking, ADMET and MD Simulations |
Misha Swetangkumar Patel, Manali Singh, Mitesh B. Solanki |
| 2 |
[GO] |
2024―May―31 |
Evaluating therapeutic potential of AYUSH-64 constituents against omicron variant of SARS-CoV-2 using ensemble docking and simulations |
Vinod Jani, Shruti Koulgi, Mallikarjunachari V.N. Uppuladinne, Saket Ram Thrigulla, Manohar Gundeti, Goli Penchala Prasad, et al. (+4) Sanjaya Kumar, Srikanth Narayanam, Uddhavesh Sonavane, Rajendra Joshi |
| 3 |
[GO] |
2024―Apr―29 |
The impact of SARS-CoV-2 Spike mutation on peptide presentation is HLA allomorph-specific |
You Min Ahn, Janesha C. Maddumage, Emma J. Grant, Demetra S.M. Chatzileontiadou, W.W.J. Gihan Perera, Brian M. Baker, et al. (+2) Christopher Szeto, Stephanie Gras |
| 4 |
[GO] |
2024―Jan―05 |
Specific binding of G-quadruplex in SARS-CoV-2 RNA by RHAU peptide |
Le Tuan Anh Nguyen, Thao Thu Thi Nguyen, Dung Thanh Dang |
| 5 |
[GO] |
2023―Dec―15 |
Natural flavonoid pectolinarin computationally targeted as a promising drug candidate against SARS-CoV-2 |
Mukta Rani, Amit Kumar Sharma, R.S. Chouhan, Souvik Sur, Rani Mansuri, Rajesh K. Singh |
| 6 |
[GO] |
2023―Oct―05 |
Taking stock of the mutations in human SARS-CoV-2 spike proteins: From early days to nearly the end of COVID-19 pandemic |
Lalitha Guruprasad, Gatta KRS. Naresh, Ganesh Boggarapu |
| 7 |
[GO] |
2022―Nov―26 |
Insights into the structural properties of SARS-CoV-2 main protease |
Ibrahim Yagiz Akbayrak, Sule Irem Caglayan, Lukasz Kurgan, Vladimir N. Uversky, Orkid Coskuner-Weber |
| 8 |
[GO] |
2022―Jun―23 |
Integrative structural studies of the SARS-CoV-2 spike protein during the fusion process (2022) |
Jacob C. Miner, Paul W. Fenimore, William M. Fischer, Benjamin H. McMahon, Karissa Y. Sanbonmatsu, Chang-Shung Tung |
| 9 |
[GO] |
2022―May―16 |
Multifaceted membrane binding head of the SARS-CoV-2 spike protein |
Anh Tran, Troy A. Kervin, Michael Overduin |
| 10 |
[GO] |
2022―Mar―08 |
Energy landscape of the SARS-CoV-2 reveals extensive conformational heterogeneity |
Ghoncheh Mashayekhi, John Vant, Abbas Ourmazd, Abhishek Singharoy |
| 11 |
[GO] |
2022―Feb―09 |
Mutations in human SARS-CoV-2 spike proteins, potential drug binding and epitope sites for COVID-19 therapeutics development |
Kunchur Guruprasad |
| 12 |
[GO] |
2021―Nov―13 |
A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features |
Saman Fatihi, Surabhi Rathore, Ankit K. Pathak, Deepanshi Gahlot, Mitali Mukerji, Nidhi Jatana, Lipi Thukral |
| 13 |
[GO] |
2020―Dec―11 |
Dual Targeting of 3CLpro and PLpro of SARS-CoV-2: A Novel Structure-Based Design Approach to treat COVID-19 |
Sajjan Rajpoot, Manikandan Alagumuthu, Mirza S. Baig |
